A study on Thippili Nei (Medicated ghee) in the management of Swasakaasam (Bronchial Asthma)
Phase 3
- Conditions
- Health Condition 1: J454- Moderate persistent asthma
- Registration Number
- CTRI/2023/02/049661
- Lead Sponsor
- ational Institute of Siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with clinical symptoms of Wheezing, Cough with or without expectoration, Dyspnea, tightness of chest H/O Wheezing minimum 2 episodes per week
2.Patients who are willing to undergo Pulmonary Function Test (FEV1- 50-80%) will be taken
3.Patients who are willing to undergo radiological investigation and provide blood sample for lab investigation
Exclusion Criteria
1.Having Covid 19 (or) recent history of covid 19 infection
2. Restrictive Lung diseases
3.Tuberculosis
4.Cardiac diseases
5. Renal diseases
6. Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Outcome is assessed by comparing the lung volumes and capacities in pre and post treatment using Pulmonary function test reports <br/ ><br>2. Changes in the clinical symptoms by Asthma Control Questionnaire (ACQ) <br/ ><br>3.Changes in the labaratory parameters IgE, AEC, ESR before and after treatmentTimepoint: 2 Month - SCREENING <br/ ><br>2 Months - PATIENT ENROLLEMENT <br/ ><br>2 Month - OUTCOME ASSESMENT
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI